- Home
- Bharat Biotech
India approves Oxford’s, Bharat Biotech’s COVID-19 vaccines for restricted emergency use
Bharat Biotech recruits 23k volunteers for COVID-19 vaccine trials
Bharat Biotech on course to have 26,000 volunteers for Phase-3 clinical trials of Covaxin
Covaxin can work against mutated Covid-19 virus, says Bharat Biotech Chairman
Bharat Biotech, Ocugen to co-develop Covaxin for US market
Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin
How is govt preparing for COVID-19 vaccination in the country?
Free COVID-19 vaccine for all in Kerala: CM Vijayan
Country’s first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBT
Will take COVID-19 vaccine; safety, efficacy not a concern: Kiran Mazumdar-Shaw
Over 60 foreign envoys visit leading pharma companies in Hyderabad
Bharat Biotech’s intranasal COVID-19 vaccine to enter phase 1 trials next month
Bharat Biotech seeks emergency use authorisation for indigenously developed COVID-19 vaccine Covaxin
Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India
Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
Bharat Biotech confirms volunteer was hospitalised during Covaxin vaccine trial, says illness unrelated
Bharat Biotech’s Covid-19 vaccine ‘Covaxin’ enters phase-3 trials
Bharat Biotech planning to launch Covid-19 vaccine ‘Covaxin’ in second quarter of 2021
Bharat Biotech’s ‘COVAXIN’ gets approval for phase 3 trials in India
Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial
Latest Additions
Bidar: CID begins investigation into contractor suicide case
Andhra Pradesh-based start-up tests ultra-high-frequency communication tech on ISRO’s POEM-4
‘Medical seats can’t remain vacant’: SC asks Centre to hold talks with stakeholders
World”s ”fastest violinist” will be in ”conversation” with L Subramaniam in Bengaluru on Jan 4
Gadag: Engineer dies by suicide in lodge